Willem Houck is the specialist in healthcare innovation within Van Holland Group, with a proven track record in both blue chip companies and rapidly growing startups. From our offices in New York and Houston, Willem not only assists healthcare organizations but also supports broader technology and business challenges.
Experience & Expertise
Healthcare & Biotech: As CEO, Willem led biotech companies developing groundbreaking solutions for HIV and oncological diseases. At DEARhealth (UCLA spin-out), he directed the use of AI for clinical decision-making.
Innovator & Entrepreneur: He was one of the first to recognize the potential of automated, personalized care in the U.S. (founder of Daklapack US) and co-founded the Health Care Financial Exchange, which made healthcare payments more transparent and competitive.
Technology & Early-Stage: As the founder of Girasol NY and involved with NICO-lab, iValue UAB, and iDx Ventures, Willem focuses on medical devices, AI diagnostics, and digital health innovations.
Executive Leadership: With turnaround experience at Philips B2B and iFortress, he knows how to restructure organizations and drive them towards customer-focused success.
Education & Background
Willem holds a law degree, a bilingual MBA (HEC Paris, focused on strategic marketing), and senior executive programs completed at IMD and INSEAD.
He is an American-Dutch citizen, commuting between New York and The Hague, and served as the chairman of the Netherland Club of New York for almost ten years.
Value Added for Your Organization
With Willem on board, you gain not only a healthcare expert but also a strategic thinker who can solve broad business challenges. He supports clients in the U.S. and beyond from New York and Houston with innovation, growth, and results.